Trump’s COVID ‘Blessing’; Regeneron Seeks EUA; NEJM Takes Election Stand

Note that some links may require registration or subscription.

President Trump called his coronavirus infection a “blessing from God” and attributed his recovery to the Regeneron antibody cocktail. (CNN)

Regeneron announced it is putting that treatment up for emergency use authorization by the FDA. (Bloomberg)

While last night’s vice presidential debate featured considerable discussion of COVID-19, both candidates dodged some of the questions. (The Hill)

Now at least 34 people connected to the White House have new COVID-19 infections, according to an internal FEMA memo. (ABC News)

Trump’s personal attorney Rudy Giuliani said he’s taking hydroxychloroquine for prevention. (The Hill)

“[O]ur current political leaders have demonstrated that they are dangerously incompetent. We should not abet them and enable the deaths of thousands more Americans by allowing them to keep their jobs, ” say editors of the New England Journal of Medicine.

Trump’s physician said the president had detectable levels of SARS-CoV-2 IgG antibodies on Monday. Then again, Trump had received the Regeneron antibodies, social media users pointed out.

Tentative planning has Trump returning to the campaign trail as early as Monday. (Bloomberg)

A digital health passport, CommonPass, is being tested by Cathay Pacific Airways and United Airlines as a way for travelers to document their COVID-19 status as part of a given country’s entry requirements. (mobihealthnews)

Abbott touted new study results supporting the accuracy of its rapid ID NOW COVID-19 test, which the White House had used for screening staff and visitors. (Reuters)

Pittsburgh study recruiters described the difficulties enrolling Black people into a coronavirus vaccine trial. (New York Times)

Protesting a new lockdown ordered for certain New York City hotspots, one Orthodox Jewish community in Brooklyn set fires in the street and beat a man who urged people to wear masks. (CBS News)

FDA warned Battelle Memorial Institute for not having a process for reporting adverse events related to its decontamination system for N95 respirators.

In other news: